Stepped Care for Posttraumatic Stress Disorder Study
This study is testing different ways to help people with Post Traumatic Stress Disorder (PTSD). It compares several behavioral treatments: webSTAIR (an online program), webSTAIR plus coaching, Brief STAIR (a short therapy with a clinician), and Written Exposure Therapy (WET, another short therapy with a clinician). The study aims to see how well these treatments reduce PTSD symptoms, how many people stay in treatment, and how acceptable the treatments are. You might be able to join if you are at least 18, a Boston Medical Center primary care patient, have access to a computer or mobile device, can receive treatment in English or Spanish, and have a PTSD diagnosis. The study plans to enroll 428 participants.
- Study design
- This study is an interventional study that will enroll 428 participants. It uses a special design where participants are first assigned to one treatment, and if their symptoms don't improve enough, they are then assigned to a different treatment.
- What's involved
- You would participate in online modules or individual sessions for up to 30 weeks. Your PTSD symptoms and how you feel about the treatment will be checked at different times.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your PTSD symptom severity, treatment retention, and treatment acceptability will be measured up to 30 weeks.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Stepped Care for Posttraumatic Stress Disorder Study
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Sarah Valentine, PhD · PRINCIPAL_INVESTIGATOR · Boston Medical Center, Psychiatry
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- PTSD symptom severitybaseline, 4 weeks, 8 weeks, 18 weeks, 30 weeks
This outcome will be assessed by the PTSD Checklist for the DSM-5 (PCL-5), a 20-item self-report measure that evaluates the degree to which individuals have been bothered by PTSD symptoms in the past month tied to their most distressing event. Total scores ranging from 0 to 80, and a score of 31-33 or higher suggests probable PTSD and potential benefit from treatment.
- Treatment retention4 weeks, 8 weeks, 18 weeks
as the proportion (%) of participant who complete 60% of interventions in the treatment windows.
- Treatment acceptability4 weeks, 8 weeks, 18 weeks, 30 weeks
This outcome will be assessed with the Client Satisfaction Questionnaire 8 \[CSQ-8\], a 8-item instruction where scores are summed across items once. Items 2, 4, 5, and 8 are reverse scored. Total scores range from 8 to 32, with the higher number indicating greater satisfaction.